Amgen, Horizon Say FTC Constitutionality Key To Merger Row
Amgen and Horizon Therapeutics urged an Illinois federal judge Thursday to preserve their attacks on the constitutionality of the Federal Trade Commission and its in-house process as part of the agency...To view the full article, register now.
Already a subscriber? Click here to view full article